Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2014, Article ID 179586, 10 pages
http://dx.doi.org/10.1155/2014/179586
Research Article

Absence of Autophagy-Related Proteins Expression Is Associated with Poor Prognosis in Patients with Colorectal Adenocarcinoma

1Department of Biomedical Science, The Catholic University of Korea College of Medicine, Seoul 137-701, Republic of Korea
2Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Uijeongbu 480-717, Republic of Korea
3Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea
4Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul 137-701, Republic of Korea

Received 17 December 2013; Accepted 21 January 2014; Published 5 March 2014

Academic Editor: Robert Odze

Copyright © 2014 Ji Hye Choi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Levine and G. Kroemer, “Autophagy in the pathogenesis of disease,” Cell, vol. 132, no. 1, pp. 27–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Mizushima, B. Levine, A. M. Cuervo, and D. J. Klionsky, “Autophagy fights disease through cellular self-digestion,” Nature, vol. 451, no. 7182, pp. 1069–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Mathew, V. Karantza-Wadsworth, and E. White, “Role of autophagy in cancer,” Nature Reviews Cancer, vol. 7, no. 12, pp. 961–967, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Qu, J. Yu, G. Bhagat et al., “Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1809–1820, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Yue, S. Jin, C. Yang, A. J. Levine, and N. Heintz, “Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 15077–15082, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. K. N. Dalby, I. Tekedereli, G. Lopez-Berestein, and B. Ozpolat, “Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer,” Autophagy, vol. 6, no. 3, pp. 322–329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Roy and J. Debnath, “Autophagy and tumorigenesis,” Seminars in immunopathology, vol. 32, no. 4, pp. 383–396, 2010. View at Google Scholar · View at Scopus
  8. M. P. Tschan and H.-U. Simon, “The role of autophagy in anticancer therapy: promises and uncertainties,” Journal of Internal Medicine, vol. 268, no. 5, pp. 410–418, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Abedin, D. Wang, M. A. McDonnell, U. Lehmann, and A. Kelekar, “Autophagy delays apoptotic death in breast cancer cells following DNA damage,” Cell Death and Differentiation, vol. 14, no. 3, pp. 500–510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. S. Carew, S. T. Nawrocki, C. N. Kahue et al., “Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHAto overcome Bcr-Abl-mediated drug resistance,” Blood, vol. 110, no. 1, pp. 313–322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Nishikawa, N. H. Tsuno, Y. Okaji et al., “Inhibition of autophagy potentiates sulforaphane-induced apoptosis in human colon cancer cells,” Annals of Surgical Oncology, vol. 17, no. 2, pp. 592–602, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Pisani, D. M. Parkin, F. Bray, and J. Ferlay, “Estimates of the worldwide mortality from 25 cancers in 1990,” International Journal of Cancer, vol. 83, no. 1, pp. 18–29, 1999. View at Google Scholar
  13. T. Watanabe, T.-T. Wu, P. J. Catalano et al., “Molecular predictors of survival after adjuvant chemotherapy for colon cancer,” The New England Journal of Medicine, vol. 344, no. 16, pp. 1196–1206, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. C. B. Diep, L. Thorstensen, G. I. Meling, E. Skovlund, T. O. Rognum, and R. A. Lothe, “Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients,” Journal of Clinical Oncology, vol. 21, no. 5, pp. 820–829, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Arango, P. Laiho, A. Kokko et al., “Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer,” Gastroenterology, vol. 129, no. 3, pp. 874–884, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Sato, K. Tsuchihara, S. Fujii et al., “Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation,” Cancer Research, vol. 67, no. 20, pp. 9677–9684, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Nakatogawa, K. Suzuki, Y. Kamada, and Y. Ohsumi, “Dynamics and diversity in autophagy mechanisms: lessons from yeast,” Nature Reviews Molecular Cell Biology, vol. 10, no. 7, pp. 458–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. X. H. Liang, S. Jackson, M. Seaman et al., “Induction of autophagy and inhibition of tumorigenesis by beclin 1,” Nature, vol. 402, no. 6762, pp. 672–676, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Yoshioka, H. Miyata, Y. Doki et al., “LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers,” International Journal of Oncology, vol. 33, no. 3, pp. 461–468, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. D. J. Klionsky, “Autophagy: from phenomenology to molecular understanding in less than a decade,” Nature Reviews Molecular Cell Biology, vol. 8, no. 11, pp. 931–937, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Kononen, L. Bubendorf, A. Kallioniemi et al., “Tissue microarrays for high-throughput molecular profiling of tumor specimens,” Nature Medicine, vol. 4, no. 7, pp. 844–847, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. H. Ko, Y. S. Cho, H. S. Won et al., “Prognostic significance of autophagy-related protein expression in resected pancreatic ductal adenocarcinoma,” Pancreas, vol. 42, no. 5, pp. 829–835, 2013. View at Google Scholar
  23. C. H. Ahn, E. G. Jeong, and J. W. Lee, “Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers,” Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 115, no. 5, pp. 1344–1349, 2007. View at Google Scholar
  24. B.-X. Li, C.-Y. Li, R.-Q. Peng et al., “The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers,” Autophagy, vol. 5, no. 3, pp. 303–306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. I. Koukourakis, A. Giatromanolaki, E. Sivridis, M. Pitiakoudis, K. C. Gatter, and A. L. Harris, “Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia,” British Journal of Cancer, vol. 103, no. 8, pp. 1209–1214, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Myung Park, S. Huang, T. T. Wu, N. R. Foster, and F. A. Sinicrope, “Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy,” Cancer Biology & Therapy, vol. 14, no. 2, pp. 100–107, 2013. View at Google Scholar
  27. A. Giatromanolaki, E. Sivridis, S. Mendrinos, A. V. Koutsopoulos, and M. I. Koukourakis, “Autophagy proteins in prostate cancer: relation with anaerobic metabolism and Gleason score,” Urologic Oncology, vol. 32, no. 1, pp. 39.e11–39.e18, 2013. View at Google Scholar
  28. E. Sivridis, M. I. Koukourakis, C. E. Zois et al., “LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas,” American Journal of Pathology, vol. 176, no. 5, pp. 2477–2489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Giatromanolaki, M. I. Koukourakis, A. L. Harris, A. Polychronidis, K. C. Gatter, and E. Sivridis, “Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas,” Journal of Clinical Pathology, vol. 63, no. 10, pp. 867–872, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Y. Zheng, X. Y. Zhang, X. F. Wang, and B. C. Sun, “Autophagy enhances the aggressiveness of human colorectal cancer cells and their ability to adapt to apoptotic stimulus,” Cancer Biology & Medicine, vol. 9, no. 2, pp. 105–110, 2012. View at Google Scholar
  31. G.-F. Guo, W.-Q. Jiang, B. Zhang et al., “Autophagy-related proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer,” World Journal of Gastroenterology, vol. 17, no. 43, pp. 4779–4786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. D. H. Cho, Y. K. Jo, S. C. Kim, I. J. Park, and J. C. Kim, “Down-regulated expression of ATG5 in colorectal cancer,” Anticancer Research, vol. 32, no. 9, pp. 4091–4096, 2012. View at Google Scholar
  33. Y. K. Jo, S. C. Kim, I. J. Park et al., “Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis,” PLoS ONE, vol. 7, no. 12, Article ID e52705, 2012. View at Google Scholar
  34. K. Koneri, T. Goi, Y. Hirono, K. Katayama, and A. Yamaguchi, “Beclin 1 gene inhibits tumor growth in colon cancer cell lines,” Anticancer Research, vol. 27, no. 3, pp. 1453–1457, 2007. View at Google Scholar · View at Scopus
  35. M. L. Slattery, J. D. Potter, K. Curtin et al., “Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer,” Cancer Research, vol. 61, no. 1, pp. 126–130, 2001. View at Google Scholar · View at Scopus
  36. S. Wangefjord, J. Manjer, A. Gaber, B. Nodin, J. Eberhard, and K. Jirstrom, “Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study,” Biology of Sex Differences, vol. 2, article 10, 2011. View at Publisher · View at Google Scholar
  37. J. H. Koo and R. W. L. Leong, “Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer,” Journal of Gastroenterology and Hepatology, vol. 25, no. 1, pp. 33–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Lista, E. Straface, S. Brunelleschi, F. Franconi, and W. Malorni, “On the role of autophagy in human diseases: a gender perspective,” Journal of Cellular and Molecular Medicine, vol. 15, no. 7, pp. 1443–1457, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Mizushima, T. Yoshimori, and B. Levine, “Methods in mammalian autophagy research,” Cell, vol. 140, no. 3, pp. 313–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Pankiv, T. H. Clausen, T. Lamark et al., “p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy*,” The Journal of Biological Chemistry, vol. 282, no. 33, pp. 24131–24145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Mathew, C. M. Karp, B. Beaudoin et al., “Autophagy suppresses tumorigenesis through elimination of p62,” Cell, vol. 137, no. 6, pp. 1062–1075, 2009. View at Publisher · View at Google Scholar